Abstract
Paget’s disease is a chronic disorder of the adult skeleton characterized by increased resorption and deposition of bone resulting in replacement of the normal matrix with a softened and enlarged bone. Initially, there is active resorption by large and increased numbers of osteoclasts containing multiple nuclei, followed by deposition of bone by numerous osteoblasts which most often results in a weakened disorganized bony structure that is interspersed with areas of fibrosis. Although localized to isolated areas of the skeleton, there may be widespread bony distribution.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Altman RD, Bloch DA, Hochberg MC, Murphy WA. Prevalence of pelvic Paget’s disease of bone in the United States. J Bone Miner Res 2000;15:461–465.
Michou L, Collet C, Laplanche JL, Orcel P, Cornelis F. Genetics of Paget’s disease of bone. Joint Bone Spine 2006;73:243–248.
Kurihara N, Zhou H, Reddy SV, et al. Expression of measles virus nucleocapsid protein in Osteoclasts induces Paget’s disease-like bone lesions in mice. J Bone Miner Res 2006;21:446–455.
Altman RD. Musculoskeletal manifestations of Paget’s disease of bone. Arthritis Rheum 1980;23:1121–1127.
Woo S-B, Hellstein JW, Kalmar JR. Systematic review: bisphosphonates and osteonecrosis of the jaw. Ann Intern Med 2006;144:753–761.
Walsh JP, Ward LC, Stewart GO, et al. A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget’s disease of bone. Bone 2004;34:747–754.
Altman RD, Johnston CC, Khairi MRA, Wellman H, Serafini AN, Sankey RR. Influence of disodium etidronate on clinical and laboratory manifestations of Paget’s disease of bone (osteitis deformans). N Engl J Med 1973;289:1379–1384.
Vasireddy S. Talwalkar A, Miller H, Mehan R, Swinson DR. Patterns of pain in Paget’s disease of bone and their outcomes on treatment with pamidronate. Clin Rheumatol 2003;22:376–380.
Crandall C. Risedronate: a clinical review. Arch Intern Med 2001;161:353–360.
Morales-Piga A. Tiludronate. A new treatment for an old ailment: Paget’s disease of bone. Expert Opin Pharmacother 1999;1:157–170.
Reid IR, Miller P, Lyles K, et al. Comparison of a single infusion of zoledronic acid with risedronate for Paget’s disease. N Engl J Med 2005;353:898–908.
Martin TJ. Treatment of Paget’s disease with calcitonins. Aust N Z J Med 1979;9:36–43.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Altman, R.D. (2008). Paget’s Disease of Bone. In: Klippel, J.H., Stone, J.H., Crofford, L.J., White, P.H. (eds) Primer on the Rheumatic Diseases. Springer, New York, NY. https://doi.org/10.1007/978-0-387-68566-3_34
Download citation
DOI: https://doi.org/10.1007/978-0-387-68566-3_34
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-35664-8
Online ISBN: 978-0-387-68566-3
eBook Packages: MedicineMedicine (R0)